Haemonetics Corp. (HAE)
118.78
-2.51
(-2.07%)
USD |
NYSE |
Oct 16, 14:11
Haemonetics SG&A Expense (TTM) : 451.54M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 451.54M |
| March 31, 2026 | 443.32M |
| December 31, 2025 | 436.85M |
| September 30, 2025 | 434.15M |
| June 30, 2025 | 439.48M |
| March 31, 2025 | 437.01M |
| December 31, 2024 | 443.33M |
| September 30, 2024 | 448.59M |
| June 30, 2024 | 446.54M |
| March 31, 2024 | 431.78M |
| December 31, 2023 | 407.48M |
| September 30, 2023 | 390.42M |
| June 30, 2023 | 377.93M |
| March 31, 2023 | 376.68M |
| December 31, 2022 | 371.14M |
| September 30, 2022 | 357.20M |
| June 30, 2022 | 340.57M |
| March 31, 2022 | 339.56M |
| December 31, 2021 | 331.43M |
| September 30, 2021 | 324.15M |
| June 30, 2021 | 320.07M |
| March 31, 2021 | 298.39M |
| December 31, 2020 | 293.26M |
| September 30, 2020 | 298.08M |
| June 30, 2020 | 296.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 299.68M |
| December 31, 2019 | 299.71M |
| September 30, 2019 | 295.32M |
| June 30, 2019 | 302.73M |
| March 31, 2019 | 298.28M |
| December 31, 2018 | 298.69M |
| September 30, 2018 | 322.67M |
| June 30, 2018 | 318.21M |
| March 31, 2018 | 316.52M |
| December 31, 2017 | 310.59M |
| September 30, 2017 | 283.69M |
| June 30, 2017 | 282.02M |
| March 31, 2017 | 302.66M |
| December 31, 2016 | 312.60M |
| September 30, 2016 | 320.58M |
| June 30, 2016 | 324.03M |
| March 31, 2016 | 324.14M |
| December 31, 2015 | 320.72M |
| September 30, 2015 | 324.54M |
| June 30, 2015 | 334.74M |
| March 31, 2015 | 339.69M |
| December 31, 2014 | 347.34M |
| September 30, 2014 | 354.14M |
| June 30, 2014 | 350.88M |
| March 31, 2014 | 365.13M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ICU Medical, Inc. | 615.07M |
| Merit Medical Systems, Inc. | 482.07M |
| Teleflex, Inc. | 943.66M |
| Globus Medical, Inc. | 1.217B |
| Abbott Laboratories | 13.94B |